Cited by 204Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima

Pentikäinen, M. O., Öörni, K., Ala‐Korpela, M., Kovanen, P. T.·2000·Journal of Internal Medicine

DOI 10.1046/j.1365-2796.2000.00655.x

Open this paper in CoChat — free account

Abstract

Abstract. Pentikäinen MO, Öörni K, Ala‐Korpela M, Kovanen PT (Wihuri Research Institute, Helsinki, Finland). Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima (Minisymposium). J Intern Med 2000; 247: 359–370. Atherosclerosis is characterized by chronic inflammation of an injured intima. The pathological processes are initiated by accumulation of morphologically distinct, modified forms of LDL, and followed by cellular infiltration and foam cell formation. Activated intimal cells secrete enzymes and agents capable of modifying LDL, and the modified lipids of LDL, in turn, are able to activate intimal cells and to trigger various inflammatory signals. These processes can initiate and maintain a vicious circle in the intima and lead to lesion progression. In this review, we focus on the LDL modifications relevant to the initial lipid accumulation and discuss their pro‐inflammatory effects.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2796.2000.00655.x

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Beyond Cholesterol
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
Esterbauer, H., Gebicki, J. M., Puhl, H., & Jürgens, G. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90181-f · Cited by 2,307
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,105
SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION
Saikku, P., Mattila, K. J., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,961
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
Ylä‐Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S. S., Witztum, J. L., & Steinberg, D. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,877
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,648
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626

Show all 103 references

Research works printed but not linked: 1

Virchow R., 1856, Gesammelte Abhandlungen Zur Wissenschaftlichen Medizin, 458

Sorted by citations

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Self-citation
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2
Roberts, W. L., Moulton, L., Law, T. C., Farrow, G., Cooper-Anderson, M., Savory, J., & Rifai, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.418 · Cited by 652
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Li, Z.-M., Xu, S., & Liu, P. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.193 · Cited by 567
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Praticò, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J. O., & Ren, J. T. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07166-8 · Cited by 532
Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL
Hevonoja, T., Pentikäinen, M. O., Hyvönen, M., Kovanen, P. T., & Ala‐Korpela, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00123-2 · Cited by 439
Self-citation
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
Aviram, M., & Rosenblat, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.030 · Cited by 434
Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences
Fredrikson, G. N., Söderberg, I., Lindholm, M., Dimayuga, P. C., Chyu, K., Shah, P. K., & Nilsson, J. Å. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067937.93716.db · Cited by 261
Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells
Covey, S. D., Krieger, M., Wang, W., Penman, M., & Trigatti, B. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000083343.19940.a0 · Cited by 221
Phospholipase A2in Vascular Disease
Hurt‐Camejo, E., Camejo, G., Peilot, H., Öörni, K., & Kovanen, P. T. (2001) · Circulation Research · doi:10.1161/hh1601.095598 · Cited by 219
Self-citation
Beyond the Laboratory
Halcox, J., & Deanfield, J. E. (2004) · Circulation · doi:10.1161/01.cir.0000129500.29229.92 · Cited by 200
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration
Curcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r002238 · Cited by 203
Biochemical properties and regulation of cathepsin K activity
Lecaille, F., Brömme, D., & Lalmanach, G. (2007) · Biochimie · doi:10.1016/j.biochi.2007.08.011 · Cited by 183
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
Summerhill, V. I., Grechko, A. V., Yet, S., Sobenin, I. A., & Orekhov, A. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143561 · Cited by 167
Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Bairaktari, E. T., Seferiadis, K. I., & Elisaf, M. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000106 · Cited by 142
Clinical implications for statin pleiotropy
Liao, J. K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191913.16321.60 · Cited by 139
Mast cells: multipotent local effector cells in atherothrombosis
Kovanen, P. T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00515.x · Cited by 133
Self-citation
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers
Wang, I., Zhang, B., Yang, X., Zhu, J., Stepaniants, S., Zhang, C., Meng, Q., Peters, M. A., He, Y. D., Ni, C., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.24 · Cited by 130
Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation
Martinet, W., & Kockx, M. M. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00009 · Cited by 129
Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
Poznyak, A. V., Wu, W., Melnichenko, A. А., Wetzker, R., Sukhorukov, V. N., Markin, A. M., Khotina, V. A., & Orekhov, A. N. (2020) · Cells · doi:10.3390/cells9030584 · Cited by 110
Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood
Ahn, J. S., Choi, S., Jang, S. H., Chang, H., Kim, J., Nahm, K. B., Oh, S. W., & Choi, E. Y. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00113-x · Cited by 110
Lipoprotein Lipase in the Arterial Wall
Pentikäinen, M. O., Oksjoki, R. K., Öörni, K., & Kovanen, P. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101551 · Cited by 108
Self-citation
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression
Fredrikson, G. N., Andersson, L. I. M., Söderberg, I., Dimayuga, P. C., Chyu, K., Shah, P. K., & Nilsson, J. Å. (2005) · Autoimmunity · doi:10.1080/08916930500050525 · Cited by 102
Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
Orekhov, A. N., Bobryshev, Y. V., Sobenin, I. A., Melnichenko, A. А., & Chistiakov, D. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712807 · Cited by 100
Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions
Fu, T., & Borensztajn, J. (2002) · Biochemical Journal · doi:10.1042/bj20020045 · Cited by 97
Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients
Tesoriere, L., D’Arpa, D., Butera, D., Allegra, M., Renda, D., Maggio, A., Bongiorno, A., & Livrea, M. A. (2001) · Free Radical Research · doi:10.1080/10715760100300461 · Cited by 93
Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature
Kumar, V., Butcher, S. J., Öörni, K., Engelhardt, P., Heikkonen, J., Kaski, K. K., Ala‐Korpela, M., & Kovanen, P. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018841 · Cited by 92
Self-citation
Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
Khuseyinova, N., Imhof, A., Rothenbacher, D., Trischler, G., Kuelb, S., Scharnagl, H., Maerz, W., Brenner, H., & Köenig, W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.046 · Cited by 89
The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification
Carracedo, M., Artiach, G., Arnardottir, H. H., & Bäck, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00767-y · Cited by 100
Metabolism of oxidized LDL by macrophages
Jessup, W., & Kritharides, L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00005 · Cited by 86
Cyclodextrins: Potential therapeutics against atherosclerosis
Mahjoubin‐Tehran, M., Kovanen, P. T., Xu, S., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107620 · Cited by 76
Self-citation
Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
Lorey, M. B., Öörni, K., & Kovanen, P. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841545 · Cited by 82
Self-citation
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection
Gopal, R., Marinelli, M. A., & Alcorn, J. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570681 · Cited by 77
Role of extracellular retention of low density lipoproteins in atherosclerosis
Borén, J., Gustafsson, M. V., Skålén, K., Flood, C., & Innerarity, T. L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00002 · Cited by 75
Evaluation of a high-affinity QCM immunosensor using antibody fragmentation and 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer
Kurosawa, S., Nakamura, M., Park, J.-W., Aizawa, H., Yamada, K., & Hirata, M. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.05.016 · Cited by 73
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
Zhang, M., Shen, Y., Shi, J., & Yu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.610561 · Cited by 75
Mast Cells as Potential Accelerators of Human Atherosclerosis—From Early to Late Lesions
Kovanen, P. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184479 · Cited by 73
Self-citation
Sterol regulatory element binding protein (SREBP) -1 mediates oxidized low-density lipoprotein (oxLDL) induced macrophage foam cell formation through NLRP3 inflammasome activation
Varghese, J. F., Patel, R. P., & Yadav, U. C. S. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.10.020 · Cited by 67
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
Solly, E. L., Dimasi, C. G., Bursill, C. A., Psaltis, P. J., & Tan, J. T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122199 · Cited by 68
Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein
Taskinen, S., Kovanen, P. T., Jarva, H., Meri, S., & Pentikäinen, M. O. (2002) · Biochemical Journal · doi:10.1042/bj20020492 · Cited by 65
Self-citation
The effects of cornelian cherry on atherosclerosis and atherogenic factors in hypercholesterolemic rabbits
Rafieian‐Kopaei, M., Asgary, S., Adelnia, A., Setorki, M., Khazaei, M., Kazemi, S., & Shamsi, F. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001202 · Cited by 64
Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing
Oh, S. W., Moon, J. D., Park, S. Y., Jang, H. J., Kim, J. H., Nahm, K. B., & Choi, E. Y. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.01.026 · Cited by 64
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis
Cedó, L., Metso, J., Santos, D., García‐León, A., Plana, N., Sabaté‐Soler, S., Rotllán, N., Rivas-Urbina, A., Méndez‐Lara, K. A., Tondo, M., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316424 · Cited by 62
Self-citation
New insights into immunological aspects of atherosclerosis
Jawień, J. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.332 · Cited by 62
Effects of Seal Oil and Tuna‐Fish Oil on Platelet Parameters and Plasma Lipid Levels in Healthy Subjects
Mann, N. J., O’Connell, S. L., Baldwin, K. M., Singh, I., & Meyer, B. J. (2010) · Lipids · doi:10.1007/s11745-010-3450-z · Cited by 61
Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View
Lee‐Rueckert, M., Lappalainen, J., Kovanen, P. T., & Escolá‐Gil, J. C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.777822 · Cited by 59
Self-citation
Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables
Holsworth, R., Cho, Y. I., Weidman, J. J., Sloop, G. D., & Cyr, J. A. S. (2013) · Perfusion · doi:10.1177/0267659113505637 · Cited by 61
Future of Anticathepsin K Drugs: Dual Therapy for Skeletal Disease and Atherosclerosis?
Podgorski, I. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.4 · Cited by 54
Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway
Apostolov, E. O., Basnakian, A. G., Yin, X., Ok, E., & Shah, S. V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01079.2006 · Cited by 52
Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding
Sánchez‐Quesada, J. L., Villegas, S., & Ordóñez‐Llanos, J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357c933 · Cited by 51
Quantification of Atherosclerosis in Mice
Centa, M., Ketelhuth, D. F. J., Malin, S., & Gisterå, A. (2019) · Journal of Visualized Experiments · doi:10.3791/59828 · Cited by 55
Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves
Lehti, S., Käkelä, R., Hörkkö, S., Kummu, O., Suihko, S., Kupari, M. M., Werkkala, K., Kovanen, P. T., & Öörni, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065810 · Cited by 48
Self-citation
The periodontal pathogen Porphyromonas gingivalis cleaves apoB‐100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation
Bengtsson, T., Karlsson, H., Gunnarsson, P., Skoglund, C., Elison, C., Leanderson, P., & Lindahl, M. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01917.x · Cited by 49
Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein
Jaarsveld, H. V., & Pool, G. F. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00638-4 · Cited by 48
Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach
Möckel, M. M., Müller, R., Vollert, J. O., Müller, C., Danne, O., Gareis, R., Störk, T. V., Dietz, R., & Köenig, W. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0540-x · Cited by 48
Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field
Adam, C. A., Șalaru, D. L., Prisacariu, C., Marcu, D. T. M., Sascău, R. A., & Stătescu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094998 · Cited by 49
Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis
Kijani, S., Vázquez, A. M., Levin, M. C., Borén, J., & Fogelstrand, P. (2017) · Physiological Reports · doi:10.14814/phy2.13334 · Cited by 44
Lipid Parameters are Independently Associated with Cardio–Ankle Vascular Index (CAVI) in Healthy Japanese Subjects
Nagayama, D., Watanabe, Y., Saiki, A., Shirai, K., & Tatsuno, I. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.42291 · Cited by 45
The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs
DiMarco, D. M., & Fernández, M. L. (2015) · Biology · doi:10.3390/biology4030494 · Cited by 44
Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment
Yang, B., Hang, S., Xu, S., Gao, Y., Yu, W., Zang, G., Zhang, L., & Wang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32073 · Cited by 46
Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis
Vliegen, I., Duijvestijn, A. M., Stassen, F. R. M., & Bruggeman, C. A. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.05.020 · Cited by 40
Pro-inflammatory action of LDL(−) on mononuclear cells is counteracted by increased IL10 production
Benı́tez, S., Bancells, C., Ordóñez‐Llanos, J., & Sánchez‐Quesada, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.03.001 · Cited by 40
Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too Late
Williams, K. J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320065 · Cited by 41
Molecular and cellular mechanisms of macrophage survival in atherosclerosis
Martinet, W., Schrijvers, D. M., & Meyer, G. R. Y. D. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0297-x · Cited by 37
The impact of mast cells on cardiovascular diseases
Kritikou, E., Kuiper, J., Kovanen, P. T., & Bot, I. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.050 · Cited by 38
Self-citation
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
Dehnavi, S., Sadeghi, M., Penson, P. E., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111856 · Cited by 37
Antibody immobilization to phospholipid polymer layer on gold substrate of quartz crystal microbalance immunosensor
Park, J., Kurosawa, S., Takai, M., & Ishihara, K. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.11.032 · Cited by 35
Mast cell tryptase – Marker and maker of cardiovascular diseases
Mohajeri, M., Kovanen, P. T., Bianconi, V., Pirro, M., Cicero, A. F. G., & Sahebkar, A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.008 · Cited by 36
Self-citation
LDL electronegativity index: a potential novel index for predicting cardiovascular disease
Bobryshev, Ivanova, E. A., & Orekhov, A. N. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s74697 · Cited by 34
Will autoantibodies help to determine severity and progression of atherosclerosis?
Nilsson, J. Å., & Kovanen, P. T. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200410000-00002 · Cited by 33
Self-citation
Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages
Chi, L., Peng, L., Hu, X., PAN, N., & Zhang, Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1748 · Cited by 33
HDL and Atherothrombotic Vascular Disease
Annema, W., von Eckardstein, A., & Kovanen, P. T. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_11 · Cited by 34
Self-citation
Plant Stanol Esters Reduce LDL (Low-Density Lipoprotein) Aggregation by Altering LDL Surface Lipids
Ruuth, M. K., Äikäs, L., Tigistu‐Sahle, F., Käkelä, R., Lindholm, H. J., Simonen, P. P., Kovanen, P. T., Gylling, H., & Öörni, K. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314329 · Cited by 32
Self-citation
Contemporaneous carrier-state of two or three “proatherosclerotic” variants of APOE, ICAM1, PPARA and PAI-1 genes differentiate CAD patients from healthy individuals
Żak, I., Balcerzyk, A., Sarecka, B., Niemiec, P., Ciemniewski, Z., & Dyląg, S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.06.011 · Cited by 32
Effect of nonsurgical periodontal therapy on crevicular fluid levels of Cathepsin K in periodontitis
Garg, G., Pradeep, A. R., & Thorat, M. S. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.08.007 · Cited by 32
Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis
Margiana, R., Alsaikhan, F., Al‐Awsi, G. R. L., Patra, I., Sivaraman, R., Fadhil, A. A., Al-Baghdady, H. F. A., Qasim, M. T., Hameed, N. M., Mustafa, Y. F., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110471 · Cited by 37
C-Reactive Protein Induced Rearrangement of Phosphatidylcholine on Nanoparticle Mimics of Lipoprotein Particles
Mackiewicz, M. R., Hodges, H. L., & Reed, S. M. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp911617q · Cited by 31
Potential Effects of Traditional Chinese Medicine in Anti-Aging and Aging-Related Diseases: Current Evidence and Perspectives
Ding, X., Ma, X., Meng, P., Yue, J., Li, L., & Xu, L. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s447514 · Cited by 33
OxLDL receptor chromatography from live human U937 cells identifies SYK(L) that regulates phagocytosis of oxLDL
Howard, J. C., Florentinus-Mefailoski, A., Bowden, P., Trimble, W. S., Grinstein, S., & Marshall, J. G. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.07.021 · Cited by 25
Evidence of antiplatelet aggregation effects from the consumption of tomato products, according to EFSA health claim requirements
Cámara, M., Fernández‐Ruiz, V., Sánchez‐Mata, M. D. C., Díaz, L. D., Kardinaal, A. F. M., & Lieshout, M. V. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1577215 · Cited by 30
Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait
Akanji, A. O., Abdella, N., & Mojiminiyi, O. A. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00792-6 · Cited by 28
Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins
Linke, M., Gordon, R. E., Brillard‐Bourdet, M., Lecaille, F., Lalmanach, G., & Brömme, D. (2006) · Biological Chemistry · doi:10.1515/bc.2006.160 · Cited by 28
Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress
Xu, Y., Yuan, Q., Cao, S., Cui, S., Li, X., Song, X., Li, Z., Xu, R., Yuan, Q., & Li, R. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.075 · Cited by 25
Leukocyte Trafficking via Lymphatic Vessels in Atherosclerosis
Yeo, K. P., Lim, H. Y., & Angeli, V. (2021) · Cells · doi:10.3390/cells10061344 · Cited by 23
Exploring the regulatory roles of circular RNAs in the pathogenesis of atherosclerosis
Sun, X., Deng, K., Zang, Y., Zhang, Z., Zhao, B., Fan, J., & Huang, L. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106898 · Cited by 21
Determination of Oxidized Low‐Density Lipoproteins (ox‐LDL) versus ox‐LDL/β2GPI Complexes for the Assessment of Autoimmune‐Mediated Atherosclerosis
Lopez, L. R., Buckner, T. R., HURLEY, B. L., Kobayashi, K., & Matsuura, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.036 · Cited by 23
Diabetic Dyslipidaemia in Kuwait
Akanji, A. (2002) · Medical Principles and Practice · doi:10.1159/000066409 · Cited by 29
Pancreatic Enzymes and Microvascular Cell Activation in Multiorgan Failure
Schmid‐Schönbein, G. W., Hugli, T. E., Kistler, E. B., Sofianos, A., & Mitsuoka, H. (2001) · Microcirculation · doi:10.1111/j.1549-8719.2001.tb00153.x · Cited by 21
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Rivas-Urbina, A., Rull, A., Ordóñez‐Llanos, J., & Sánchez‐Quesada, J. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180330093953 · Cited by 20
Chitin oligosaccharides alleviate atherosclerosis progress in ApoE-/- mice by regulating lipid metabolism and inhibiting inflammation
Zhen, H., Yan, Q., Liu, Y., Li, Y., Yang, S., & Jiang, Z. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.03.027 · Cited by 21
Two decades of vaccine development against atherosclerosis
Moreno‐Gonzalez, M. A., Ortega-Rivera, O. A., & Steinmetz, N. F. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101822 · Cited by 21
Complement Protein C1q Recognizes Enzymatically Modified Low-Density Lipoprotein through Unesterified Fatty Acids Generated by Cholesterol Esterase
Bı́ró, A., Ling, W. L., & Arlaud, G. J. (2010) · Biochemistry · doi:10.1021/bi9021022 · Cited by 20
Characterization and molecular detection of atherothrombosis by magnetic resonance—potential tools for individual risk assessment and diagnostics
Ala‐Korpela, M., Sipola, P., & Kaski, K. K. (2006) · Annals of Medicine · doi:10.1080/07853890600862418 · Cited by 19
Self-citation
Equisetin protects from atherosclerosis in vivo by binding to STAT3 and inhibiting its activity
Yang, Y., Wang, J., Tian, Y., Li, M., Xu, S.-H., Zhang, L., Luo, X., Tan, Y., Liang, H., & Chen, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107289 · Cited by 18
[Role of inflammation in atherogenesis].
Rodríguez, G., Mago, N., & Rosa, F. (2009) · PubMed · Cited by 26
Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses
Wang, Y., Butler, L. M., Hansson, G. K., Yan, Z.-Q., Söderberg-Nauclér, C., Assinger, A., & Ketelhuth, D. F. J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-12-1026 · Cited by 18
Electronegative LDL: a useful biomarker of cardiovascular risk?
Sánchez‐Quesada, J. L., Estruch, M., Benı́tez, S., & Ordóñez‐Llanos, J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.26 · Cited by 18
Acidity increases the uptake of native LDL by human monocyte-derived macrophages
Plihtari, R., Kovanen, P. T., & Öörni, K. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.013 · Cited by 17
Self-citation
Low-Density Lipoprotein Modified by Macrophage-Derived Lysosomal Hydrolases Induces Expression and Secretion of IL-8 Via p38 MAPK and NF-κB by Human Monocyte-Derived Macrophages
Hakala, J. K., Lindstedt, K. A., Kovanen, P. T., & Pentikäinen, M. O. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000245796.97133.ad · Cited by 16
Self-citation
Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus
Sánchez‐Quesada, J. L., & Pérez, A. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.11.007 · Cited by 16

Authors: Pentikäinen, M. O., Öörni, K., Ala‐Korpela, M., & Kovanen, P. T.
Affiliations: Wihuri Research Institute (FI)
Corresponding author: Kovanen, P. T.
ORCID: Pentikäinen, M. O.
Öörni, K.
Ala‐Korpela, M.
Kovanen, P. T.
Venue: Journal of Internal Medicine
Publisher: Wiley
Published: 2000-03
Volume: 247
Issue: 3
Pages: 359-370
ISSN: 0954-6820 (ISSN-L)
1365-2796
DOI: 10.1046/j.1365-2796.2000.00655.x
OpenAlex: W2021937355
Cited by: 204
References: 103
Citations by year: 2026: 1 · 2025: 9 · 2024: 10 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 11 · 2019: 17 · 2018: 7 · 2017: 2 · 2016: 5 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 10
FWCI: 1.01
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 664 d)
Locations: Journal of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: modified LDL, atherosclerosis, arterial intima, inflammation, foam cell formation, lipid accumulation, pro-inflammatory effects, lesion progression
MeSH terms: Arteriosclerosis, Humans, Inflammation, Cholesterol, LDL, Tunica Intima

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks